|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1401 K Street NW Suite 1200 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 35800-48
|
||||||||
|
6. House ID# 307700021
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jack S. Deuser, President and Chief Executive Officer |
Date | 7/20/2020 2:42:45 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
PL 116-136 CARES Act (all sections of full text)
HR 6800 Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act (Division C - Health Provisions)
Monitored S 3432 Securing America's Medicine Cabinet Act of 2020
Monitored HR 6708 Securing America's Medicine Cabinet Act of 2020
Monitored S 3537 Protecting our Pharmaceutical Supply Chain from China Act
Monitored HR 3482 Protecting our Pharmaceutical Supply Chain from China Act
Monitored S 3538 Strengthening America's Supply Chain and National Security Act
Monitored HR 6393 Strengthening America's Supply Chain and National Security Act
Monitored S 3627 Medical Supply Transparency and Delivery Act
Monitored HR 6711 Medical Supply Transparency and Delivery Act
Monitored S 3847 COVID-19 Emergency Manufacturing Act of 2020
Monitored HR 6810 Health Care Protection Act
Monitored HR 6514 The Worker Health Coverage Protection Act
HR 3502 Protecting People From Surprise Medical Bills Act (all sections of full text)(support)
S 1266 Protecting Patients from Surprise Medical Bills Act (all sections of full text)(support)
S 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 (all sections of full text)(support)
S 1895 Lower Health Care Costs Act, Title I (all sections of full text)(oppose)
S 2741 Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019
HR 4932 Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2019
Monitored HR 3062 Patient Access to Higher Quality Health Care Act of 2019
Monitored HR 861 The End Surprise Billing Act of 2019
Monitored HR 3630 No Surprises Act
Monitored implementation of Sec. 6001 of the Affordable Care Act of 2010
Monitored discussions pertinent to health care group purchasing organizations (GPOs) role in helping to prevent drug shortages
Monitored Executive Order #13877 Improving Price Quality Transparency in American Healthcare To Put Patients First
Monitored HR 4379 Under-Performing Directories that Affect Treating Emergencies Act
Monitored S 2408 Telehealth Across State Lines Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James C. |
Free |
|
|
|
W. Timothy |
Locke |
|
|
|
Robert |
Hickmott |
|
|
|
Jack S. |
Deuser |
|
|
|
Trevor |
Kolego |
|
|
|
Chris |
Scribner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Discussions regarding the Centers for Medicare and Medicaid (CMS) implementation and expansion of the Accelerated and Advance Payments Program under the CARES Act
HR 1384 Medicare for All Act of 2019 (all sections of full text)(oppose)
Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills
Discussions pertaining to the Centers for Medicare and Medicaid (CMS) implementation and expansion of the Accelerated and Advance Payments Program under the CARES Act
Monitored S 2543 Prescription Drug Pricing Reduction Act, Sec. 109
Monitored HR 3 Elijah E. Cummings Lower Drug Costs Now Act of 2019
Monitored H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019
Monitored HR 2000 Medicare-X Choice Act of 2019
Monitored S 981 Medicare-X Choice Act of 2019
Monitored S 470 Medicare at 50 Act
Monitored HR 1301 The Mental Health Telemedicine Expansion Act of 2019
Monitored HR 1559 The 340B Protection and Accountability Act of 2019
Monitored HR 1332 The Fair Care Act of 2019
Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act
Monitored proposed reduction on the amount of Medicare bad debt/uncompensated care payments to hospitals for Medicare beneficiaries who fail to pay their cost-sharing obligations for treatments provided by the hospital
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James C. |
Free |
|
|
|
W. Timothy |
Locke |
|
|
|
Jack S. |
Deuser |
|
|
|
Robert |
Hickmott |
|
|
|
Trevor |
Kolego |
|
|
|
Chris |
Scribner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code COM
16. Specific lobbying issues
Monitored implementation of PL 116-105 Pallone-Thune Telephone Robocall Abuse Criminal Enforcement and Deterrence Act
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
W. Timothy |
Locke |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |